Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours (British Journal of Cancer, 2011)

(untitled) - Medley, L; Morel, A; Farrugia, D; Reed, N; Hayward, N; Davies, J; Kirichek, O; Thakker, R; Talbot, D